Platinum drugs

Publication Title: 
Critical Reviews in Oncology/Hematology

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting side-effect without any FDA-approved treatment option. Prior reviews focus mostly on pharmacological interventions, but nonpharmaceutical interventions have also been evaluated.

Author(s): 
Brami, Cloé
Bao, Ting
Deng, Gary
Publication Title: 
Critical Reviews in Oncology/Hematology

Chemotherapy-induced peripheral neuropathy (CIPN) is a serious dose-limiting side-effect without any FDA-approved treatment option. Prior reviews focus mostly on pharmacological interventions, but nonpharmaceutical interventions have also been evaluated.

Author(s): 
Brami, Cloé
Bao, Ting
Deng, Gary
Subscribe to RSS - Platinum drugs